É o que não
aparece no espelho.


É o que não se
mede na balança.

 

É o que não aparece no espelho.

É o que não se mede na balança.

 

É o impacto silencioso que causa no corpo, muito além da imagem.

É o desgaste das articulações, o excesso de gordura no fígado,
o retrabalho do coração.

É o risco iminente que ninguém vê.

Por isso, propomos uma nova forma de
olhar para a obesidade.

Olhar primeiro para o que mais importa a partir de quem mais importa.

Um novo ponto de vista: de dentro para fora.

#saudenaosepesa

 

É o impacto silencioso que causa
no corpo, muito além da imagem.
É o desgaste das articulações,
o excesso de gordura no fígado,
o retrabalho do coração.

É o risco de vida iminente
que ninguém vê.

Por isso, a Novo Nordisk está propondo uma nova
forma de olhar para a obesidade.

Olhar primeiro para o que mais importa
a partir de quem mais importa.

Um novo ponto de vista:
de dentro para fora.

Junte-se a essa campanha! Compartilhe fotos, vídeos e mensagens em suas redes sociais.

Mostre o que você faz para manter sua saúde sob controle e use a hashtag
#saúdenãosepesa


 Referências: 
1.
WHO. Consultation on Obesity 1998 http://whqlibdoc.who.int/hq/1998/WHO_NUT_NCD_98.1(p1-158).pdf. Acesso em: 06.11.2014. 2. Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373(9669):1083-1096. 3. WHO. Obesity and Overweight Factsheet no. 311. Available at: www.who.int/mediacentre/factsheets/fs311/en/. Acesso em: 10.04.15. 4. Vigitel Brazil 2014, Ministry of Health. Available at: www.ans.gov.br/images/stories/Materiais_para_pesquisa/Materiais_por_assunto/2015_vigitel.pdf. Acesso em: 06.15.16. 5. National Health and Medical Research Council (2013) Clinical practice guidelines for the management of overweight and obesity in adults, adolescents and children in Australia. Melbourne: National Health and Medical Research Council. 6. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009; 9:88. 7. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999; 282(16):1523-1529. 8. Li C, Ford ES, Zhao G, Croft JB, Balluz LS, Mokdad AH. Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006. Prev Med. 2010; 51(1):18-23. 9. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014; 384(9945):755-765. 10. Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss.N Engl J Med. 2011; 365(17):1597-1604. 11. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Eng J Med 1990; 322:1483-7. 12. Silventoionen K, Rokholm B, Kaprio J, Sorensen T. The genetic and environmental influences on childhood obesity: a systematic review of twin and adoption studies. Int J Obes (Lond) 2010; 34:29-40. 13. Allison DB, Kaprio J, Korkeila M, et al. The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Dis 1996; 20:501–6. 14. Allison DB, Faith MS, Nathan JS. Risch’s lambda values for human obesity. Int J Obes Relat Metab Disord 1996; 20:990–9. 15. Herrera B, Keildson S, Lindgren C. Genetics and epigenetics of obesity. Maturitas 2011; 69:41-49. 16. World Health Organization. Obesity and overweight, Fact sheet N°311, Updated January 2015. Available at www.who.int/mediacentre/factsheets/fs311/en/ 17. Sumithran P, et al. N Engl J Med 2011; 365:1597–1604. Schwartz A, et al. Obes Rev 2010; 11:531–547. 18. Knowler WC, Barrett-Connor E, Fowler SE, et al; for the Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. 19. Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011; 34(7):1481-1486. 20. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992; 56(2):320-328. 21. Tuomilehto H, Seppa J, Uusitupa M, et al. The impact of weight reduction in the prevention of the progression of obstructive sleep apnea: an explanatory analysis of a 5-year observational follow-up trial. Sleep Med. 2014; 15(3):329-335. 22. Foster GD, Borradaile KE, Sanders MH, et al; for the Sleep AHEAD study. Arch Intern Med.2009; 169(17):1619-1626. 23. ABESO. Diretrizes Brasileiras de Obesidade 2016. http://www.abeso.org.br/uploads/downloads/92/57fccc403e5da.pdf. Acesso em: 05/09/2017.  24. Obesity Education Initiative; National Heart, Lung, and Blood Institute; National Institutes of Health; US Department of Health and Human Services. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD: National Institutes of Health; 1998. NIH publication 98-4083. 25. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1-253. 26. Jensen MD, Ryan DH, Donato KA, et al. Executive summary: guidelines (2013) for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society published by the Obesity Society and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Based on a systematic review from the Obesity Expert Panel 2013. Obesity (Silver Spring) 2014; 22: Suppl 2: S5-S39. 27. American Medical Association. AMA adopts new policies on second day of voting at annual meeting. Viewed 11th August 2015, www.ama-assn.org/ama/pub/news/news/2013/2013-06-18-new-ama-policies-annual-meeting.page. 28. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403. 29. Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2014; 2: 474-80. 30. Warkentin LM, Das D, Majumdar SR, Johnson JA, Padwal RS. The effect of weight loss on health-related quality of life: systematic review and meta-analysis of randomized trials. Obes Rev 2014; 15:169-82. 31. Wing R, Lang W, Wadden T. Beneftis of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011; 34:1481-6. 32. Gaesser G, Angadi S, Sawyer B. Exercise and diet, independent of weight loss, improve cardiometabolic risk profile in overweight and obese individuals. Phys Sportsmed 2011; 39(2):87–97. 33. Purcell K, Sumithran P, Prendergast L, Bouniu C Delbridge E, Proietto J. The effect of rate of weight loss on long-term weight management: a randomized controlled trial. Lancet Diabetes Endocrinol 2014; 2:954-62. 34. Kaufer-Horwitz M, Villa M, Pedraza J et al. Knowledge of appropriate foods and beverages needed for weight loss and diet of patients win an obesity clinic. Eur J Clin Nutr 2015; 69:68-72. ,